bioXXmed AG (T5O) Stock Price & News

All values in EUR	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Revenue	8.50K	8.50K	-134.00	-134.00
Cost of goods sold	-	-	-	-
Cost of revenue	-	-	-	-
Research and development expenses	-	-	-	-
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	6.50K	6.50K	8.67K	8.67K
Operating expense	138.00K	138.00K	5.98K	5.98K
Total operating expenses	138.00K	138.00K	5.98K	5.98K
Operating income	-129.50K	-129.50K	-6.11K	-6.11K
Other non operating income	3.00K	3.00K	3.72K	3.72K
EBT including unusual items	-128.00K	-128.00K	-54.74K	-54.74K
EBT excluding unusual items	-128.00K	-128.00K	-4.74K	-4.74K
Income tax expense	-	-	-46.00	-46.00
Effective tax rate	-	-	0.08%	0.08%
Other operating expenses	85.00K	85.00K	43.79K	43.79K
Net income	-128.00K	-128.00K	-54.70K	-54.70K
Net profit margin	-1,505.88%	-1,505.88%	40,817.16%	40,817.16%
Earnings per share	-	-	-	-
Interest and investment income	-	-	38.00	38.00
Interest expense	-1.50K	-1.50K	-2.38K	-2.38K
Net interest expenses	-1.50K	-1.50K	-2.34K	-2.34K
Depreciation and amortization charges	46.50K	46.50K	-46.48K	-46.48K
EBITDA	-129.48K	-129.48K	-6.09K	-6.10K
Gain or loss from assets sale	-	-	-	-

AI content may include mistakes. Learn more

Finance